Market Newsdesk

PG&E Foundation Funding to Provide $5,000 Grants to 188 Restaurants and Commercial Caterers; Applications Being Accepted

OAKLAND, Calif.
, April 10, 2025 /PRNewswire/ — For the fifth consecutive year, The PG&E Corporation Foundation (PG&E Foundation) will provide grants to support independent restaurant owners and their staffs. They are doing so through the California Restaurant Foundation‘s (CRF) Restaurants Care Resilience Fund. The grants will support a record number of restaurants in Northern and Central California this year.

Resilience Fund applications are being accepted at www.restaurantscare.org/resilience through April 26, 2025.

The PG&E Foundation is contributing $1.1 million to the program this year. The funding will help build more resilient hometown businesses for the long term. A total of 188 restaurants and commercial caterers in Pacific Gas and Electric Company’s (PG&E) service area will receive $5,000 grants. That number is up from last year’s 154 grant recipients.

Since 2021, PG&E and the PG&E Foundation have contributed $4.3 million to the CRF’s Restaurants Care Resilience Fund. This has provided grants ranging from $3,000 to $5,000 to local restaurants within PG&E’s service area. With this year’s funding, 863 restaurants in Northern and Central California will have benefitted from the grants.

“Our local restaurants have great stories to share, including stories of perseverance. They also have stories as the gathering spots for meaningful and celebratory occasions in our communities. Partnering with the California Restaurant Foundation reflects our commitment to our hometown restaurants. Their success strengthens our local economies and communities,” said Carla Peterman, Executive Vice President, Corporate Affairs, PG&E Corporation, and Chair of the Board, The PG&E Corporation Foundation.

Supporting Fire Victims and Giving Locally

Across California, CRF’s Restaurants Care Resilience Fund will provide nearly $3.5 million in restaurant grants. This includes a dedicated grant for restaurants impacted by the Los Angeles fires.

Grants can be used for vital business needs including technology and equipment upgrades. They can also help with employee training and retention, and unforeseen hardships.

One of last year’s grants recipients was Whitey’s Jolly Kone. Established in 1963 by Emile “Whitey” Boisclair. It is one of West Sacramento’s oldest, family-owned restaurants.

“Receiving the grant is a great honor and feels like recognition of our efforts at Whitey’s Jolly Kone to continue to grow and serve our community. As third-generation owner-operators, we aim to revitalize the foundation that our grandfather and parents established for us, by expanding and upgrading a family-friendly space to meet the needs of the current and ever-growing community throughout Sacramento,” said Jennifer Havson, co-owner of Whitey’s Jolly Kone.

(See our “From Kitchen to Community” video series.  The series features restaurant grant recipients in PG&E’s service area.)

CRF began the Resilience Fund in 2021. It started to support restaurants recovering from economic impacts of the COVID-19 pandemic. The pandemic contributed to many restaurants closing their doors temporarily or permanently. PG&E and The PG&E Corporation Foundation have supported the program since its inception. The company has maintained its support as restaurants continue weathering fluctuations in the economy.

“The generosity and unwavering support of donors like PG&E ensures California’s independent restaurants can survive challenges and thrive for years to come,” said Alycia Harshfield, President of the California Restaurant Foundation. “The resilience of our restaurants is truly inspiring. Thanks to the kindness of our donors, we can continue providing critical relief to the local businesses that bring a sense of community to neighborhoods throughout California.”

Apply Now through April 26

Grant applications are being accepted through April 26, 2025. California-based restaurant owners and commercial caterers in PG&E’s service area can apply. Applicants can have up to five locations (although only one location can apply). They must have less than $3 million in annual revenue for the applicant restaurant location. Priority will be given to restaurants that have not previously received a grant. Former recipients may still apply.

The PG&E Foundation’s funding for this charitable donation comes from PG&E shareholders, not PG&E customers.

Assisting Restaurants and Small and Medium Businesses

PG&E remains committed to providing ways for its small and medium business customers to save energy and money, especially during times of economic hardship. Here are some ways PG&E is helping its customers:

• On-Bill Financing. PG&E offers 0% interest loans for replacing old and worn-out equipment with more energy-efficient models. Watch this video to explore how energy savings are reinvested back into your business to help improve your bottom line.
• Rebates for food service equipment. PG&E offers several rebate programs that will help you save money and improve productivity when you upgrade your food service equipment.
• Food Service Technology Center. Access key training programs, design consultants and test kitchen plans to improve your operations and energy efficiency.
• Budget Billing. If you are a small business owner, you can have a predictable bill each month by enrolling in Budget Billing. The program averages out your monthly bill to determine your monthly payment, instead of having unpredictable summer bills.
• Energy Efficiency Programs. PG&E contracts with external companies to provide a customize solution for different business sectors.
• Find Your Best Rate Plan. Customers can use this online tool to run a rate analysis to see if they are on the best rate plan for their operations. The tool is projected to save customers over $9.5 million this year.
• Economic Development Rate. This offers eligible business customers the opportunity to lower costs through one of three reduced electric rate options. PG&E developed this rate to help businesses grow or maintain jobs in California. The standard 12% rate is available throughout our service territory.

For more information on PG&E Small and Medium Business customer support, visit pge.com/smbsupport.

About The PG&E Corporation Foundation
The PG&E Corporation Foundation is an independent 501(c)(3) nonprofit organization, separate from PG&E and sponsored by PG&E Corporation.

View original content to download multimedia:https://www.prnewswire.com/news-releases/keeping-local-restaurants-cooking-the-pge-corporation-foundation-funds-restaurants-care-resilience-grants-302425897.html

SOURCE PG&E Corporation

Company surpasses its 2021-2025 ambitions in workforce development and community service contributions, while performing ahead in emissions reduction.

LAS VEGAS
, April 10, 2025 /PRNewswire/ — Las Vegas Sands (NYSE: LVS) has released its latest environmental, social and governance (ESG) report, outlining the company’s 2024 performance on the corporate responsibility priorities established for its 2021-2025 reporting period.

Most notably, Sands has surpassed two of its three primary ambitions in the areas of workforce development and community volunteerism while performing ahead of its 17.5% science-based emissions reduction target. These goals align with the company’s People, Communities and Planet corporate responsibility pillars.

At the close of 2024, Sands had spent $220 million on workforce development initiatives, accomplishing its People pillar ambition to invest $200 million by 2025. In achieving this target, Sands spent nearly $38 million in 2024 to advance job skills and career training for Team Members, hospitality industry professionals and the local labor pool in its regions.

The company also surpassed its Communities pillar target of contributing 250,000 Team Member volunteer hours by 2025, with a total of 255,955 hours amassed between 2021-2024. Sands’ Team Members logged 33,132 volunteer hours for more than 70 nonprofit organizations in 2024.

Sands’ scope 1 and 2 emissions remained below its 2025 Planet ambition of reducing emissions by 17.5% from the 2018 base year, with emissions down 50% in 2024. Implementation of energy-efficiency projects and continued purchases of energy attribute certificates drove progress in this area.

In 2024, the company also released its first low-carbon transition plan, which outlined a new 30% emissions-reduction target that complements its existing 17.5% emissions-reduction target validated by the Science Based Targets initiative (SBTi). Sands aims to achieve the new 30% target, which is aligned with the Paris Agreement to limit temperature increase to 1.5°C, by 2025.

In addition to these primary ambitions, the company made advancements in multiple areas under its People, Communities and Planet pillars in 2024.

People – Separate of the workforce development investment, Sands spent $3 billion to procure goods and services from local businesses and small and medium enterprises (SMEs) around the world, contributing to its regions’ economic health and helping sustain job opportunities. The company also invested $26 million in diverse businesses. A variety of programs support workforce and local business development, ranging from Team Member and industry training to supplier advancement through procurement academies and business development opportunities. 

Communities – In addition to the Team Member community service ambition, Sands provided $12 million in philanthropic contributions to nonprofit organizations and continued focusing on building their capacity through both funding and mentorship. The company’s signature capacity-building initiative, the Sands Cares Accelerator, incubates the strategic initiatives of nonprofit members and graduated its fourth member in 2024. Community revitalization was another top priority, and Sands China made significant investments in promoting key Macao landmarks and enabling local entrepreneurs to develop businesses in a culturally significant area.

Planet – In addition to maintaining achievement of its emissions-reduction target, Sands met or exceeded desired levels of progress in other areas, including increasing its 2024 operational waste diversion rate by 6% over the 2019 base year, tracking ahead of the 5% increase targeted by 2025. The company also prevented, rescued or diverted 29% of food waste, which is targeted for 25% by 2025.

Sands reduced potable water use intensity by 11% from the 2019 base year, which is ahead of its 3% reduction targeted by 2025. The company continued working toward goals of reducing single-use plastics by transitioning to 100% sustainable solutions for Sands-branded water bottles at the end of 2025, with 62% achieved in 2024, and procuring 100% cage-free eggs by 2028, increasing cage-free egg purchases from 3% of total eggs sourced in 2023 to 18% in 2024.

“In 2025, we are focused on closing the gaps around our 2025 goals and continuing to push ahead in  areas where we’ve achieved our ambitions or are currently surpassing our targets,” Katarina Tesarova, senior vice president and chief sustainability officer, said. “We are motivated to aim higher as we set our sights on a strong finish to our current reporting period and prepare to establish new goals for our 2026-2030 cycle.”

Underscoring Sands’ performance in 2024, the company was included in the 2024 Dow Jones Sustainability World and North America Indices, Newsweek’s 2025 America’s Most Responsible Companies list and the S&P Global Sustainability Yearbook 2025, receiving designation among the top 10% of overall global ESG scores. Sands was the only U.S.-based company in the casinos and gaming category listed in the yearbook.

For detailed information on the company’s corporate responsibility accomplishments and initiatives, read the 2024 ESG Report: https://www.sands.com/resources/reports/.

About Sands (NYSE: LVS)
Sands is the leading global developer and operator of integrated resorts. The company’s iconic properties drive valuable leisure and business tourism and deliver significant economic benefits, sustained job creation, financial opportunities for local businesses and community investment to help make its host regions ideal places to live, work and visit.

Sands’ portfolio of properties includes Marina Bay Sands^® in Singapore and The Venetian^®Macao, The Londoner Macao^®, The Parisian Macao^®, The Plaza Macao and Four Seasons Hotel Macao, and Sands^®Macao in Macao SAR, China, through majority ownership in Sands China Ltd.

Dedicated to being a leader in corporate responsibility, Sands is anchored by the core tenets of serving people, communities and the planet. The company’s ESG leadership has led to inclusion on the Dow Jones Sustainability Indices for World and North America. To learn more, visit www.sands.com.

View original content to download multimedia:https://www.prnewswire.com/news-releases/sands-releases-its-2024-environmental-social-and-governance-report-302425411.html

SOURCE Las Vegas Sands Corp.

NEW YORK
, April 10, 2025 /PRNewswire/ — Immunic, Inc. (“Immunic” or the “Company”) (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced the closing of its previously announced registered direct offering of 5,666,667 shares of its common stock at a price of $0.90 per share, led by Aberdeen Investments. All securities in the offering were sold by Immunic.

The gross proceeds from the offering were approximately $5.1 million before deducting commissions and offering expenses. The offering closed on April 10, 2025.

The Company intends to use the net proceeds received from the offering to fund its clinical trials and operations and for other general corporate purposes.

Titan Partners Group, a division of American Capital Partners, acted as the sole placement agent for the offering.

The offering was made by Immunic pursuant to a shelf registration statement on Form S-3 (File No. 333-275717) previously filed with the Securities and Exchange Commission (the “SEC”) on November 22, 2023, which became effective on May 31, 2024. The offering was made only by means of a prospectus supplement and the accompanying base prospectus that form a part of the registration statement. A final prospectus supplement relating to the offering was filed with the SEC and is available on the SEC’s website at www.sec.gov. Copies of the final prospectus supplement and the accompanying base prospectus relating to the offering, may be obtained by contacting Titan Partners Group LLC, a division of American Capital Partners, LLC, 4 World Trade Center, 29th Floor, New York, NY 10007, by phone at (929) 833-1246 or by email at [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

About Immunic, Inc.

Immunic, Inc. (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company’s lead development program, vidofludimus calcium (IMU-838), is currently in phase 3 and phase 2 clinical trials for the treatment of relapsing and progressive multiple sclerosis, respectively, and has shown therapeutic activity in phase 2 clinical trials in patients suffering from relapsing-remitting multiple sclerosis, progressive multiple sclerosis and moderate-to-severe ulcerative colitis. Vidofludimus calcium combines neuroprotective effects, through its mechanism as a first-in-class nuclear receptor related 1 (Nurr1) activator, with additional anti-inflammatory and anti-viral effects, by selectively inhibiting the enzyme dihydroorotate dehydrogenase (DHODH). IMU-856, which targets the protein Sirtuin 6 (SIRT6), is intended to restore intestinal barrier function and regenerate bowel epithelium, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease as well as inflammatory bowel disease, Graft-versus-Host-Disease and weight management. IMU-381, which currently is in preclinical testing, is a next generation molecule being developed to specifically address the needs of gastrointestinal diseases. For further information, please visit: www.imux.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future financial position, future revenue, projected expenses, sufficiency of cash and cash runway, expected timing, development and results of clinical trials, prospects, plans and objectives of management are forward-looking statements. Examples of such statements include, but are not limited to, Immunic’s development programs and the targeted diseases; the potential for Immunic’s development programs to safely and effectively target diseases; interpretation of preclinical and clinical data for Immunic’s development programs and potential effects; the timing of current and future clinical trials and anticipated clinical milestones; the nature, strategy and focus of the company and further updates with respect thereto; the development and commercial potential of any product candidates of the company; and the company’s expected cash runway. Immunic may not actually achieve the plans, carry out the intentions or meet the expectations or projections disclosed in the forward-looking statements and you should not place undue reliance on these forward-looking statements. Such statements are based on management’s current expectations and involve substantial risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, increasing inflation, tariffs and macroeconomic trends, impacts of the Ukraine – Russia conflict and the conflict in the Middle East on planned and ongoing clinical trials, risks and uncertainties associated with the ability to project future cash utilization and reserves needed for contingent future liabilities and business operations, the availability of sufficient financial and other resources to meet business objectives and operational requirements, the fact that the results of earlier preclinical studies and clinical trials may not be predictive of future clinical trial results, any changes to the size of the target markets for the Company’s products or product candidates, the protection and market exclusivity provided by Immunic’s intellectual property, risks related to the drug development and the regulatory approval process and the impact of competitive products and technological changes. A further list and descriptions of these risks, uncertainties and other factors can be found in the section captioned “Risk Factors,” in the company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on March 31, 2025, and in the company’s subsequent filings with the SEC. Copies of these filings are available online at www.sec.gov or ir.imux.com/sec-filings. Any forward-looking statement made in this release speaks only as of the date of this release. Immunic disclaims any intent or obligation to update these forward-looking statements to reflect events or circumstances that exist after the date on which they were made. Immunic expressly disclaims all liability in respect to actions taken or not taken based on any or all of the contents of this press release.

Contact Information

Immunic, Inc.

Jessica Breu

Vice President Investor Relations and Communications
+49 89 2080 477 09
[email protected]

US IR Contact
Rx Communications Group
Paula Schwartz
+1 917 633 7790
[email protected]

US Media Contact
KCSA Strategic Communications
Caitlin Kasunich
+1 212 896 1241
[email protected]

View original content to download multimedia:https://www.prnewswire.com/news-releases/immunic-inc-announces-closing-of-5-1-million-registered-direct-offering-led-by-aberdeen-investments-302425909.html

SOURCE Immunic, Inc.